Physician profile
Patrick R Pagan
NPI 1346241395
$1,438.53
in general payments reported to CMS, 2019-2025
17 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $240 · 2022: $258 · 2023: $221 · 2024: $389 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $353.10 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $214.22 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $189.16 | 2021-2024 | Xarelto |
| Amgen INC. | $166.75 | 2021-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $127.37 | 2025 | Assure Wcd |
| Pfizer INC. | $66.63 | 2022-2024 | |
| Boston Scientific Corporation | $51.01 | 2023-2025 | Watchman, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $43.94 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $40.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.15 | 2023-2025 | |
| Philips North America LLC | $31.74 | 2024 | (Ck7) Extended Holter |
| Glaxosmithkline, LLC. | $31.14 | 2025 | Shingrix, Arexvy |
| Kiniksa Pharmaceuticals International, Plc | $22.00 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $21.64 | 2023 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $15.75 | 2023 | Inpefa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15.72 | 2025 | Inspire |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Pagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.